{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-075039","form_type":"8-K","ticker":"ABBV","cik":"0001551152","company_name":"AbbVie Inc.","filed_at":"2022-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.159581+00:00","generated_at":"2026-06-24T22:39:05.828449+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"AbbVie appoints Robert Michael as Vice Chairman and President; Scott Reents as CFO","bullets":["Robert A. Michael, previously CFO, named Vice Chairman and President effective June 23, 2022.","Scott T. Reents, formerly VP Tax and Treasury, appointed Senior Vice President and CFO effective June 23, 2022.","Both appointments are internal promotions; Michael joined Abbott in 1993, Reents in 2008."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-075039","json":"https://secwatch.observer/filing/0001104659-22-075039.json","markdown":"https://secwatch.observer/filing/0001104659-22-075039.md","text":"https://secwatch.observer/filing/0001104659-22-075039.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551152/000110465922075039/0001104659-22-075039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551152/000110465922075039/tm2219549d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T22:39:05.828449+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e1e7f0dd0","claim":"Robert A. Michael was appointed as Vice Chairman and President at AbbVie Inc..","evidence_excerpt":"Robert A. Michael, 51, has been appointed Vice Chairman and President, effective June 23, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551152/000110465922075039/0001104659-22-075039-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Vice Chairman and President"}],"fact_type":"executive_change"},{"claim_id":"661c16f5a7","claim":"Scott T. Reents was appointed as Senior Vice President, Chief Financial Officer at AbbVie Inc..","evidence_excerpt":"Scott T. Reents, 55, has been appointed Senior Vice President, Chief Financial Officer, effective June 23, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551152/000110465922075039/0001104659-22-075039-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}